on TRANSGENE (EPA:TNG)
Temporary Suspension of Trading in Transgene Shares on Euronext Paris
Transgene, a Strasbourg-based biotechnology company, has announced the temporary suspension of trading in its shares on Euronext Paris. This suspension is pending an announcement regarding the company's capital increase. Trading was halted at the market opening on November 26, 2025.
The company anticipates that negotiations will resume on November 28, 2025, at market opening. This decision reflects the importance and significance of the ongoing capital increase, the details of which are expected to be announced shortly.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all TRANSGENE news